SONJCPFA
RVNC

State of New Jersey Common Pension Fund A’s Revance Therapeutics, Inc. RVNC Stock Holding History

State of New Jersey Common Pension Fund A’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$819K Buy
+26,000
New +$812K ﹤0.01% 761

Other funds holding RVNC

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

State of New Jersey Common Pension Fund A's RVNC Position: Q1 2014 in Review

State of New Jersey Common Pension Fund A opened a new position in Revance Therapeutics, Inc. (RVNC) in Q1 2014: 26,000 shares worth $819K. The stake represents ﹤0.01% of the portfolio and ranks #761 among its holdings.

66 funds tracked by Wall St. Rank hold RVNC as of Q1 2014.

  • State of New Jersey Common Pension Fund A held 26,000 shares of Revance Therapeutics, Inc. worth $819K as of Q1 2014.
  • Revance Therapeutics, Inc. was a new State of New Jersey Common Pension Fund A position in Q1 2014.
  • Revance Therapeutics, Inc. made up ﹤0.01% of State of New Jersey Common Pension Fund A's portfolio in Q1 2014, its #761 holding.
  • 66 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2014.

Based on State of New Jersey Common Pension Fund A's 13F filing for Q1 2014, filed 5 May 2014.